Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 23b (miR-23b) is a small, non-coding RNA molecule that plays a crucial role in the post-transcriptional regulation of gene expression. It functions primarily by binding to complementary sequences in target messenger RNAs (mRNAs), leading to their degradation or translational repression. miR-23b regulates several key cellular processes, including cell proliferation, differentiation, and apoptosis. It has been implicated in cancer, autoimmune diseases, and neurological disorders. Its expression levels are often altered in various diseases and are associated with clinical outcomes, making it a potential biomarker and therapeutic target.
Binds to complementary sequences in target mRNAs, leading to their degradation or translational repression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 23b (miR-23b).